Vanguard Group’s Performant Healthcare Inc PHLT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-3,976,003
Closed -$30.7M 4424
2025
Q3
$30.7M Buy
3,976,003
+55,079
+1% +$351K ﹤0.01% 2408
2025
Q2
$15.7M Buy
3,920,924
+95,901
+3% +$272K ﹤0.01% 2674
2025
Q1
$11.3M Sell
3,825,023
-38,711
-1% -$100K ﹤0.01% 2776
2024
Q4
$11.7M Buy
3,863,734
+13,765
+0.4% +$47.3K ﹤0.01% 2869
2024
Q3
$14.4M Buy
3,849,969
+62,982
+2% +$215K ﹤0.01% 2774
2024
Q2
$11M Buy
3,786,987
+123,651
+3% +$355K ﹤0.01% 2861
2024
Q1
$10.8M Buy
3,663,336
+59,043
+2% +$169K ﹤0.01% 2923
2023
Q4
$11.3M Buy
3,604,293
+67,455
+2% +$177K ﹤0.01% 2876
2023
Q3
$7.99M Buy
3,536,838
+31,330
+0.9% +$79.5K ﹤0.01% 3013
2023
Q2
$9.46M Buy
3,505,508
+322,929
+10% +$935K ﹤0.01% 2978
2023
Q1
$10.8M Buy
3,182,579
+587,452
+23% +$1.92M ﹤0.01% 2893
2022
Q4
$9.37M Buy
2,595,127
+14,447
+0.6% +$33.8K ﹤0.01% 2976
2022
Q3
$4.77M Buy
2,580,680
+99,436
+4% +$231K ﹤0.01% 3355
2022
Q2
$6.53M Buy
2,481,244
+210,116
+9% +$522K ﹤0.01% 3228
2022
Q1
$7.06M Buy
2,271,128
+110,993
+5% +$261K ﹤0.01% 3333
2021
Q4
$5.21M Buy
2,160,135
+6,905
+0.3% +$20.6K ﹤0.01% 3588
2021
Q3
$8.53M Buy
2,153,230
+522,775
+32% +$2.31M ﹤0.01% 3340
2021
Q2
$6.11M Buy
1,630,455
+376,790
+30% +$1.07M ﹤0.01% 3484
2021
Q1
$2.7M Buy
1,253,665
+134,702
+12% +$183K ﹤0.01% 3795
2020
Q4
$985K Buy
1,118,963
+750,595
+204% +$767K ﹤0.01% 3830
2020
Q3
$346K Hold
368,368
﹤0.01% 3877
2020
Q2
$240K Hold
368,368
﹤0.01% 3904
2020
Q1
$332K Hold
368,368
﹤0.01% 3764
2019
Q4
$375K Sell
368,368
-474,724
-56% -$459K ﹤0.01% 3850
2019
Q3
$927K Sell
843,092
-52,759
-6% -$62.1K ﹤0.01% 3670
2019
Q2
$941K Buy
895,851
+429,909
+92% +$726K ﹤0.01% 3692
2019
Q1
$964K Buy
465,942
+51,822
+13% +$109K ﹤0.01% 3632
2018
Q4
$931K Sell
414,120
-709,340
-63% -$1.19M ﹤0.01% 3586
2018
Q3
$2.27M Sell
1,123,460
-1,900
-0.2% -$3.99K ﹤0.01% 3485
2018
Q2
$2.42M Buy
1,125,360
+325,513
+41% +$849K ﹤0.01% 3438
2018
Q1
$2.4M Buy
799,847
+389,737
+95% +$1.02M ﹤0.01% 3396
2017
Q4
$677K Sell
410,110
-534,931
-57% -$964K ﹤0.01% 3689
2017
Q3
$1.72M Sell
945,041
-13,303
-1% -$25.2K ﹤0.01% 3444
2017
Q2
$2M Sell
958,344
-61,541
-6% -$139K ﹤0.01% 3377
2017
Q1
$2.99M Buy
1,019,885
+2,816
+0.3% +$5.45K ﹤0.01% 3255
2016
Q4
$2.39M Buy
1,017,069
+34,485
+4% +$111K ﹤0.01% 3306
2016
Q3
$2.9M Sell
982,584
-2,508
-0.3% -$5.52K ﹤0.01% 3248
2016
Q2
$1.6M Buy
985,092
+2,300
+0.2% +$3.91K ﹤0.01% 3452
2016
Q1
$1.67M Buy
982,792
+21,276
+2% +$36.9K ﹤0.01% 3445
2015
Q4
$1.72M Sell
961,516
-2,011
-0.2% -$4.58K ﹤0.01% 3449
2015
Q3
$2.33M Buy
963,527
+32,294
+3% +$93.9K ﹤0.01% 3304
2015
Q2
$3.02M Sell
931,233
-70,716
-7% -$220K ﹤0.01% 3234
2015
Q1
$3.41M Buy
1,001,949
+108,647
+12% +$551K ﹤0.01% 3184
2014
Q4
$5.94M Sell
893,302
-42,130
-5% -$308K ﹤0.01% 2804
2014
Q3
$7.56M Buy
935,432
+96,735
+12% +$931K ﹤0.01% 2624
2014
Q2
$8.47M Buy
838,697
+61,407
+8% +$560K ﹤0.01% 2576
2014
Q1
$7.03M Buy
777,290
+120,000
+18% +$1.04M ﹤0.01% 2658
2013
Q4
$6.77M Buy
657,290
+82,936
+14% +$836K ﹤0.01% 2636
2013
Q3
$6.27M Buy
574,354
+7,533
+1% +$82.2K ﹤0.01% 2622
2013
Q2
$6.57M Buy
+566,821
New +$6.31M ﹤0.01% 2520

Other funds holding PHLT

Vanguard Group's PHLT Position: Q4 2025 in Review

Vanguard Group sold out of Performant Healthcare Inc (PHLT) in Q4 2025, closing a stake of 3,976,003 shares — an estimated $30.7M sold.

Vanguard Group first reported a position in PHLT in Q2 2013 and held it in 50 quarters. The position peaked at $30.7M in Q3 2025. 1 fund tracked by Wall St. Rank holds PHLT as of Q4 2025.

  • Vanguard Group reported no remaining Performant Healthcare Inc position as of Q4 2025 after selling out during the quarter.
  • Vanguard Group sold 3,976,003 Performant Healthcare Inc shares in Q4 2025, an estimated $30.7M.
  • Vanguard Group first reported a position in Performant Healthcare Inc in Q2 2013 and held it in 50 quarters.
  • Vanguard Group's Performant Healthcare Inc position peaked at $30.7M in Q3 2025.
  • 1 fund tracked by Wall St. Rank held Performant Healthcare Inc as of Q4 2025.

Based on Vanguard Group's 13F filing for Q4 2025, filed 29 Jan 2026.